171 related articles for article (PubMed ID: 33475144)
1. Mammary Tumors Growing in the Absence of Growth Hormone Are More Sensitive to Doxorubicin Than Wild-Type Tumors.
Lantvit DD; Unterberger CJ; Lazar M; Arneson PD; Longhurst CA; Swanson SM; Marker PC
Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33475144
[TBL] [Abstract][Full Text] [Related]
2. Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments.
Thordarson G; Semaan S; Low C; Ochoa D; Leong H; Rajkumar L; Guzman RC; Nandi S; Talamantes F
Breast Cancer Res Treat; 2004 Oct; 87(3):277-90. PubMed ID: 15528971
[TBL] [Abstract][Full Text] [Related]
3. The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis.
Swanson SM; Unterman TG
Carcinogenesis; 2002 Jun; 23(6):977-82. PubMed ID: 12082019
[TBL] [Abstract][Full Text] [Related]
4. Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.
Carroll RE; Goodlad RA; Poole AJ; Tyner AL; Robey RB; Swanson SM; Unterman TG
Growth Horm IGF Res; 2009 Oct; 19(5):447-56. PubMed ID: 19406679
[TBL] [Abstract][Full Text] [Related]
5. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.
Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437
[TBL] [Abstract][Full Text] [Related]
6. Advanced rat mammary cancers are growth hormone dependent.
Shen Q; Lantvit DD; Lin Q; Li Y; Christov K; Wang Z; Unterman TG; Mehta RG; Swanson SM
Endocrinology; 2007 Oct; 148(10):4536-44. PubMed ID: 17584969
[TBL] [Abstract][Full Text] [Related]
7. Studies on prolactin and growth hormone gene expression in the pituitary gland of spontaneous dwarf rats.
Nogami H; Takeuchi T; Suzuki K; Okuma S; Ishikawa H
Endocrinology; 1989 Aug; 125(2):964-70. PubMed ID: 2752987
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ
Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf Rat.
Kamegai J; Wakabayashi I; Miyamoto K; Unterman TG; Kineman RD; Frohman LA
Neuroendocrinology; 1998 Nov; 68(5):312-8. PubMed ID: 9822798
[TBL] [Abstract][Full Text] [Related]
10. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.
van Garderen E; Schalken JA
Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808
[TBL] [Abstract][Full Text] [Related]
11. Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.
Dearth RK; Delgado DA; Hiney JK; Pathiraja T; Oesterreich S; Medina D; Dees WL; Lee AV
Cancer Prev Res (Phila); 2010 Mar; 3(3):312-21. PubMed ID: 20145191
[TBL] [Abstract][Full Text] [Related]
12. Characterization of pituitary stem/progenitor cell populations in spontaneous dwarf rats.
Sasaki K; Higuchi M
J Vet Med Sci; 2022 May; 84(5):680-688. PubMed ID: 35387959
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
Kamegai J; Unterman TG; Frohman LA; Kineman RD
Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone and Insulin-like growth factor-I (IGF-I) modulate the expression of L-type amino acid transporters in the muscles of spontaneous dwarf rats and L6 and C2C12 myocytes.
Sawa R; Nishida H; Yamamoto Y; Wake I; Kai N; Kikkawa U; Okimura Y
Growth Horm IGF Res; 2018; 42-43():66-73. PubMed ID: 30273774
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats.
Alvarado A; Lopes AC; Faustino-Rocha AI; Cabrita AMS; Ferreira R; Oliveira PA; Colaço B
Pathol Res Pract; 2017 May; 213(5):441-446. PubMed ID: 28285967
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats.
Nishida H; Ikegami A; Kaneko C; Kakuma H; Nishi H; Tanaka N; Aoyama M; Usami M; Okimura Y
PLoS One; 2015; 10(6):e0128805. PubMed ID: 26086773
[TBL] [Abstract][Full Text] [Related]
17. Increased population of nonhormone-producing cells suggests the presence of dysfunctional growth hormone cells in the anterior pituitary gland of the spontaneous dwarf rat.
Nogami H; Takeuchi T
Neuroendocrinology; 1993; 57(2):374-80. PubMed ID: 8389999
[TBL] [Abstract][Full Text] [Related]
18. Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein.
Lee R; Woo W; Wu B; Kummer A; Duminy H; Xu Z
Exp Biol Med (Maywood); 2003 Jun; 228(6):689-96. PubMed ID: 12773700
[TBL] [Abstract][Full Text] [Related]
19. Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth.
Szepeshazi K; Schally AV; Armatis P; Groot K; Hebert F; Feil A; Varga JL; Halmos G
Endocrinology; 2001 Oct; 142(10):4371-8. PubMed ID: 11564700
[TBL] [Abstract][Full Text] [Related]
20. Effects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifen.
Dias MC; Furtado KS; Rodrigues MA; Barbisan LF
BMC Complement Altern Med; 2013 May; 13():93. PubMed ID: 23634930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
